KORU Medical Systems to Participate in Upcoming Investor Conferences

MAHWAH, N.J.--(BUSINESS WIRE)-- KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use subcutaneous drug delivery systems that improve quality of life for patients, today announced that the Company will participate in two upcoming investor conferences.

KORU Medical's management is participating at the Canaccord MedTech, Diagnostics and Digital Health & Services Forum on Thursday, November 16th, 2023.

KORU Medical's management will also be participating at the 14th Annual Craig-Hallum Alpha Select Conference on Thursday, November 16th, 2023.

About KORU Medical Systems

KORU Medical Systems develops, manufactures, and commercializes innovative and easy-to-use subcutaneous drug delivery systems that improve quality of life for patients around the world. The FREEDOM Syringe Infusion System currently includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing™ and HIgH-Flo Subcutaneous Safety Needle Sets™. These devices are used for infusions administered in the home and alternate care settings. For more information, please visit www.korumedical.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231102149761/en/

Investor Contact:
Greg Chodaczek
347-620-7010
[email protected]

Source: KORU Medical Systems

You May Also Be Interested In

• NIQ Expands Local Targeting Capabilities with Launch of TDLinx Audiences
• Walker & Dunlop’s 2026 Apprise Outlook: Appraisers Have Earned a Seat at the Table Well Before CRE Deals Get Done
• Schneider Electric launches new Motivair coolant distribution unit integrating liquid and air cooling for more flexible data center deployments